These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19773638)

  • 1. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases.
    Girard N; Deshpande C; Lau C; Finley D; Rusch V; Pao W; Travis WD
    Am J Surg Pathol; 2009 Dec; 33(12):1752-64. PubMed ID: 19773638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous non-small cell lung cancers: diagnostic yield can be improved by histologic and genetic methods.
    Zhang Y; Hu H; Wang R; Ye T; Pan Y; Wang L; Zhang Y; Li H; Li Y; Shen L; Yu Y; Sun Y; Chen H; Garfield D
    Ann Surg Oncol; 2014 Dec; 21(13):4369-74. PubMed ID: 25081337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers.
    Girard N; Ostrovnaya I; Lau C; Park B; Ladanyi M; Finley D; Deshpande C; Rusch V; Orlow I; Travis WD; Pao W; Begg CB
    Clin Cancer Res; 2009 Aug; 15(16):5184-90. PubMed ID: 19671847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
    Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
    J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastases.
    Belardinilli F; Pernazza A; Mahdavian Y; Cerbelli B; Bassi M; Gradilone A; Coppa A; Pignataro MG; Anile M; Venuta F; Della Rocca C; Giannini G; d'Amati G
    Pathol Res Pract; 2021 Apr; 220():153387. PubMed ID: 33647865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines.
    Girard N; Deshpande C; Azzoli CG; Rusch VW; Travis WD; Ladanyi M; Pao W
    Chest; 2010 Jan; 137(1):46-52. PubMed ID: 19376842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive histologic analysis of ALK-rearranged lung carcinomas.
    Yoshida A; Tsuta K; Nakamura H; Kohno T; Takahashi F; Asamura H; Sekine I; Fukayama M; Shibata T; Furuta K; Tsuda H
    Am J Surg Pathol; 2011 Aug; 35(8):1226-34. PubMed ID: 21753699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach.
    Chang JC; Alex D; Bott M; Tan KS; Seshan V; Golden A; Sauter JL; Buonocore DJ; Vanderbilt CM; Gupta S; Desmeules P; Bodd FM; Riely GJ; Rusch VW; Jones DR; Arcila ME; Travis WD; Ladanyi M; Rekhtman N
    Clin Cancer Res; 2019 Dec; 25(23):7113-7125. PubMed ID: 31471310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic lung cancer subtype differentiates synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases.
    Cheng H; Lei BF; Peng PJ; Lin YJ; Wang XJ
    J Surg Res; 2017 May; 211():215-222. PubMed ID: 28501120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non-Small-Cell Lung Cancer: A Mini-Review.
    Klempner SJ; Ou SH; Costa DB; VanderLaan PA; Sanford EM; Schrock A; Gay L; Ali SM; Miller VA
    Clin Lung Cancer; 2015 Sep; 16(5):334-339.e1. PubMed ID: 25911330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Survival after surgical treatment of bilateral synchronous multiple primary non-small cell lung cancers].
    Zhang ZR; Mao YS; Gao SG; Mu JW; Xue Q; Wang DL; Gao YS; Zhao J; He J
    Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):460-5. PubMed ID: 27346405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology.
    Anagnostou VK; Lowery FJ; Zolota V; Tzelepi V; Gopinath A; Liceaga C; Panagopoulos N; Frangia K; Tanoue L; Boffa D; Gettinger S; Detterbeck F; Homer RJ; Dougenis D; Rimm DL; Syrigos KN
    BMC Cancer; 2010 May; 10():186. PubMed ID: 20459695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment.
    Dacic S; Cao X; Bota-Rabassedas N; Sanchez-Espiridion B; Berezowska S; Han Y; Chung JH; Beasley MB; Dongmei L; Hwang D; Mino-Kenudson M; Minami Y; Papotti M; Rekhtman N; Roden AC; Thunnissen E; Tsao MS; Yatabe Y; Yoshida A; Wang L; Hartman DJ; Jerome JA; Kadara H; Chou TY; Wistuba II;
    J Thorac Oncol; 2024 Feb; 19(2):273-284. PubMed ID: 37717856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases.
    Paik PK; Shen R; Won H; Rekhtman N; Wang L; Sima CS; Arora A; Seshan V; Ladanyi M; Berger MF; Kris MG
    Cancer Discov; 2015 Jun; 5(6):610-21. PubMed ID: 25929848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia.
    Loong HH; Raymond VM; Shiotsu Y; Chua DTT; Teo PML; Yung T; Skrzypczak S; Lanman RB; Mok TSK
    Clin Lung Cancer; 2018 Sep; 19(5):e601-e608. PubMed ID: 29807856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
    He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
    Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
    Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
    Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic and molecular approach to staging of multiple lung nodules.
    Schneider F; Dacic S
    Transl Lung Cancer Res; 2017 Oct; 6(5):540-549. PubMed ID: 29114470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma.
    van Rens MT; Eijken EJ; Elbers JR; Lammers JW; Tilanus MG; Slootweg PJ
    Cancer; 2002 Jan; 94(1):188-96. PubMed ID: 11815976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.